S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma

Summary

Phase II trial to study the effectiveness of bevacizumab in treating patients who have non-Hodgkin's lymphoma. Monoclonal antibodies such as bevacizumab may stop the growth of cancer by stopping blood flow to the tumor. Bevacizumab may be an effective treatment for non-Hodgkin's lymphoma

Timeline

Start

2001-04

Primary completion

2005-08

Completion

2008-09

Drugs

Indications